Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New RET inhibitors synthesized at Shanghai LiteDD

May 17, 2022

New STING agonists identified at Tyligand Bioscience

May 17, 2022

Lhotse Bio discovers lysophosphatidic acid receptor 1 antagonists

May 17, 2022

Korea University Research and Business Foundation presents new apoptosis inducers

May 16, 2022

New compounds targeting the estrogen receptor divulged by Sanofi

May 16, 2022

Medshine Discovery patents Janus kinase inhibitors

May 16, 2022

Calithera Biosciences presents new L-amino acid oxidase inhibitors

May 16, 2022

New inhibitors of G12C mutant KRAS protein identified at Amgen

May 16, 2022

Chinese researchers disclose new CDK9 inhibitors

May 13, 2022

Johns Hopkins University synthesizes MAP3K12/13 inhibitors

May 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...